Department of Pathology & Laboratory Medicine, Department of Biochemistry & Molecular Biology, Department of Molecular Microbiology and Immunology, and Section of Computational Biology in the Department of Biological Sciences, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Crit Rev Biochem Mol Biol. 2022 Jun;57(3):227-243. doi: 10.1080/10409238.2021.2004576. Epub 2021 Dec 7.
The most common human lymphoid chromosomal translocations involve concurrent failures of the recombination activating gene (RAG) complex and Activation-Induced Deaminase (AID). These are two enzymes that are normally expressed for purposes of the two site-specific DNA recombination processes: V(D)J recombination and class switch recombination (CSR). First, though it is rare, a low level of expression of AID can introduce long-lived T:G mismatch lesions at 20-600 bp fragile zones. Second, the V(D)J recombination process can occasionally fail to rejoin coding ends, and this failure may permit an opportunity for Artemis:DNA-dependent kinase catalytic subunit (DNA-PKcs) to convert the T:G mismatch sites at the fragile zones into double-strand breaks. The 20-600 bp fragile zones must be, at least transiently, in a single-stranded DNA (ssDNA) state for the first step to occur, because AID only acts on ssDNA. Here we discuss the key DNA sequence features that lead to AID action at a fragile zone, which are (a) the proximity and density of strings of cytosine nucleotides (C-strings) that cause a B/A-intermediate DNA conformation; (b) overlapping AID hotspots that contain a methyl CpG (WRCG), which AID converts to a long-lived T:G mismatch; and (c) transcription, which, though not essential, favors increased ssDNA in the fragile zone. We also summarize chromosomal features of the focal fragile zones in lymphoid malignancies and discuss the clinical relevance of understanding the translocation mechanisms. Many of the key principles covered here are also relevant to chromosomal translocations in non-lymphoid somatic cells as well.
最常见的人类淋巴样染色体易位涉及重组激活基因 (RAG) 复合物和激活诱导脱氨酶 (AID) 的并发故障。这两种酶通常用于两种位点特异性 DNA 重组过程:V(D)J 重组和类别转换重组 (CSR)。首先,尽管很少见,但 AID 的低水平表达会在 20-600bp 的脆弱区产生持久的 T:G 错配损伤。其次,V(D)J 重组过程偶尔会无法重新连接编码末端,并且这种失败可能为 Artemis:DNA 依赖性激酶催化亚基 (DNA-PKcs) 提供机会将脆弱区的 T:G 错配位点转化为双链断裂。第一个步骤需要 20-600bp 的脆弱区至少暂时处于单链 DNA (ssDNA) 状态,因为 AID 仅作用于 ssDNA。在这里,我们讨论导致脆弱区发生 AID 作用的关键 DNA 序列特征,这些特征包括:(a) 导致 B/A 中间 DNA 构象的胞嘧啶核苷酸 (C- 字符串) 的接近度和密度;(b) 重叠的 AID 热点,包含一个甲基 CpG (WRCG),AID 将其转化为持久的 T:G 错配;以及 (c) 转录,尽管不是必需的,但有利于脆弱区中增加的 ssDNA。我们还总结了淋巴样恶性肿瘤中焦点脆弱区的染色体特征,并讨论了理解易位机制的临床相关性。这里涵盖的许多关键原则也与非淋巴体细胞中的染色体易位有关。